Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 21 of 23, showing 5 Applications out of 111 total, starting on record 101, ending on 105

# Protocol No Study Title Investigator(s) & Site(s)

101.

ECCT/25/02/10   PrEP My Way II
    PrEP My Way: A hybrid type 1 clinical effectiveness-implementation trial to promote PrEP persistence among young Kenyan women   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
KEMRI RCTP
 
View

102.

ECCT/19/06/02   The A-PLUS study
    Prevention of Maternal and Neonatal Death/Infections with a Single Oral Dose of Azithromycin in Women in Labor (in Low- and Middle-Income Countries): a Randomized Controlled Trial   
Principal Investigator(s)
1. Prof Fabian Esamai Omoding Esamai
Site(s) in Kenya
1. Alupe, Sirisia, Bokoli (Bung\'oma county)
2. Nambale, Nasewa, Lukolis, Khunyangu (Busia county)
3. Mumias (Kakamega county)
 
View

103.

ECCT/20/06/07   Quality of Oxytocin and TXA
    Quality of Oxytocin and Tranexamic acid in selected facilities in six countries   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Mwingi Sub county (level 4 ) hospital (Kitui county)
2. Nyeri Level 5 Hospital (Nyeri county)
3. Garissa county referral hospital (Garissa county)
4. Embu Level 5 hospital (Embu county)
5. TIGONI LEVEL 4 HOSPTIAL (Kiambu county)
6. Meru Teaching and Referral Hospital (Meru county)
7. Kitengela Sub county Hospital (Kajiado county)
8. Mbagathi County Hospital (Nairobi City county)
9. Kakamega County Government Referral Hospital (Kakamega county)
10. St. Mary\'s Mission Hospital (Nairobi City county)
 
View

104.

ECCT/12/09/02   Reduction of EArly mortaLITY in adults and children
    Reduction of EArly mortaLITY in HIVinfected adults and children starting antiretroviral therapy (REALITY)   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
2. KEMRI Wellcome Trust Research Programme (Kilifi county)
 
View

105.

ECCT/21/05/02   BFTAF Elderly Switch Study
    Switching virally suppressed HIV-1 infected elderly adults (age ≥ 60 years) without prior confirmed virological failure from current anti-retroviral regimen to bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF)   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Kenyatta National Hospital (Nairobi City county)
2. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
View